Moleculin Biotech receives positive FDA guidance for acceleration of AML trial
Moleculin Biotech (MBRX) has received FDA feedback and guidance on its IND amendment that has allowed a reduction in the size of its Phase 3 ...
Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility
The Committed Equity Facility agreement provides Aptose the right, in its sole option and discretion without obligation, to sell and issue up to $25 million of its common shares (the “Common Shares”) ...
Le Lézard6h
Elanco Reinforces Commitment to Veterinary and Pet Owner Education
Elanco Animal Health Incorporated issued the following statement regarding its commitment to clear veterinary and pet owner education following a promotional practices warning letter from U.S. Food ...